v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning balance at Dec. 31, 2022 $ 2,072,797 $ 7,175 $ 140,539 $ (430,083) $ 2,348,183 $ 6,983
Beginning balance (in shares) at Dec. 31, 2022   97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 148,264       148,319 (55)
Other comprehensive (loss)/income            
Translation loss 31,808     31,569   239
Defined benefit plan adjustment, net of tax 916     916    
Derivative financial instruments, net of tax 2,514     2,514    
Other comprehensive (loss) income 35,238     34,999   239
Dividends (48,203)       (48,203)  
Issuance of stock awards 472   472      
Issuance of stock awards (in shares)   485        
Shares repurchased (10,576)   (10,576)      
Shares repurchased (in shares)   (175)        
Share-based compensation 7,573   7,573      
Ending balance at Apr. 02, 2023 2,205,565 $ 7,175 138,008 (395,084) 2,448,299 7,167
Ending balance (in shares) at Apr. 02, 2023   97,955        
Beginning balance at Dec. 31, 2023 $ 2,431,835 [1] $ 7,175 159,047 (366,262) 2,624,380 7,495
Beginning balance (in shares) at Dec. 31, 2023 97,957 97,957        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 65,273       65,177 96
Other comprehensive (loss)/income            
Translation loss (19,786)     (19,319)   (467)
Defined benefit plan adjustment, net of tax 43     43    
Derivative financial instruments, net of tax 169     169    
Other comprehensive (loss) income (19,574)     (19,107)   (467)
Dividends (50,348)       (50,348)  
Issuance of stock awards 204   204      
Issuance of stock awards (in shares)   460        
Shares repurchased (9,139)   (9,139)      
Shares repurchased (in shares)   (162)        
Share-based compensation 8,325   8,325      
Other 906   906      
Ending balance at Mar. 31, 2024 $ 2,427,482 $ 7,175 $ 159,343 $ (385,369) $ 2,639,209 $ 7,124
Ending balance (in shares) at Mar. 31, 2024 98,255 98,255        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the “United States” or “U.S.”).